Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact): Celiac Disease

Celiac disease is a chronic autoimmune condition triggered by gluten ingestion, resulting in small intestinal damage and a wide spectrum of clinical, economic, and humanistic consequences. This chapter explores the comprehensive role of pharmacists in the evidence-based management of celiac disease. Pharmacists contribute significantly to disease management through early identification, medication safety reviews, dietary counseling, patient education, and monitoring for complications and comorbidities. Clinically, their interventions improve symptom control, treatment adherence, and nutritional supplementation, while economically, they help reduce direct and indirect healthcare costs by promoting early detection, preventing complications, and guiding costeffective gluten-free alternatives. Humanistically, pharmacists address the psychological and emotional burdens associated with strict dietary restrictions, enhancing patients’ quality of life and satisfaction with care. Despite some barriers, such as limited time and training, pharmacist-led 170 interventions remain pivotal in delivering holistic, patient-centered care in celiac disease. This chapter underscores the importance of expanding pharmacist involvement through education, collaboration, and policy support to improve outcomes for individuals living with this lifelong condition.